Researchers have developed a new test to diagnose myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS).
The test stands out as the first successful molecular diagnostic tool for ME, a development that has been long anticipated by many healthcare providers and patients. This new tool opens up the possibility for differentiation between mild and severe cases of ME.
ME is a complex disorder characterized by extreme fatigue that lasts for at least six months and that can’t be fully explained by an underlying medical condition.1 The fatigue worsens with physical or mental activity but doesn’t improve by resting.
To read the rest of this story, click on the link below: